NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Medical Patent Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Acacia Research Corporation



Acacia Research Reports Third Quarter 2009 Financial Results



November 4th, 2009

Acacia Research Corporation (Nasdaq: ACTG) reported results for the three months ended September 30, 2009.

"Acacia Research generated $16,831,000 in licensing transactions in the third quarter of 2009, resulting in third quarter license fee revenues of $12,831,000, a decrease of 7%, compared to $13,796,000 in the year ago period, and deferred revenues of $4,000,000 which will be recognized as revenues in subsequent periods," commented Acacia Research Chairman and CEO, Paul Ryan.

"Acacia Research trailing 12-month revenues were $58,779,000, an increase of 40%, compared to $41,963,000 at the end of the third quarter of 2008."

...


Source: Medical Patent Law Weekly (2009-11-04)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login